| Autor: |
Arachchillage DRJ; Department of Haematology, Imperial College Healthcare NHS Trust, London, United Kingdom.; Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.; Department of Haematology, Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom., Shi C; Department of Emergency Medicine, Imperial College Healthcare NHS Trust, London, United Kingdom., Saliu D; Department of Emergency Medicine, Imperial College Healthcare NHS Trust, London, United Kingdom., Kozman P; Department of Emergency Medicine, Imperial College Healthcare NHS Trust, London, United Kingdom., Mi E; Department of Emergency Medicine, Imperial College Healthcare NHS Trust, London, United Kingdom., Buti N; Department of Haematology, Imperial College Healthcare NHS Trust, London, United Kingdom., Kashef E; Department of Radiology, Imperial College Healthcare NHS Trust, London, United Kingdom., Copley SJ; Department of Radiology, Imperial College Healthcare NHS Trust, London, United Kingdom., Gomez C; Department of Intensive Care and Anaesthesia, Imperial College Healthcare NHS Trust, London, United Kingdom., Leonard R; Department of Intensive Care and Anaesthesia, Imperial College Healthcare NHS Trust, London, United Kingdom., Aziz R; Department of Intensive Care and Anaesthesia, Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom., Shlebak AA; Department of Haematology, Imperial College Healthcare NHS Trust, London, United Kingdom., Laffan M; Department of Haematology, Imperial College Healthcare NHS Trust, London, United Kingdom.; Department of Immunology and Inflammation, Imperial College London, London, United Kingdom. |
| Abstrakt: |
Competing Interests: M.L. received consultancy fee from Shire, LFB, Roche, Sobi, Octapharma, Baxter, Bayer, Pfizer, CSL, and speaker bureau for Pfizer, Bayer, Roche-Chugai, Takeda, and Leo-pharma. The other authors state that they have no conflict of interest. |
